{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:19:47Z","timestamp":1740122387591,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000130","name":"National Center for Chronic Disease Prevention and Health Promotion","doi-asserted-by":"publisher","award":["NU58DP006279"],"award-info":[{"award-number":["NU58DP006279"]}],"id":[{"id":"10.13039\/100000130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10552-019-1126-4","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T07:02:47Z","timestamp":1547708567000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in lobular carcinoma in situ management: endocrine therapy use in California and New Jersey"],"prefix":"10.1007","volume":"30","author":[{"given":"Schelomo","family":"Marmor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Jerome-D\u2019Emilia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Begun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane Yuet Ching","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariella M.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Kizy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"1126_CR1","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","volume":"33","author":"TA King","year":"2015","unstructured":"King TA, Pilewskie M, Muhsen S, Patil S, Mautner SK, Park A, Oskar S et al (2015) Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol 33:3945\u20133952","journal-title":"J Clin Oncol"},{"issue":"10","key":"1126_CR2","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1245\/s10434-013-3121-4","volume":"20","author":"PR Portschy","year":"2013","unstructured":"Portschy PR, Marmor S, Nzara R, Virnig BA, Tuttle TM (2013) Trends in incidence and management of lobular carcinoma in situ: a population-based analysis. Ann Surg Oncol 20(10):3240\u20133246. \n                    https:\/\/doi.org\/10.1245\/s10434-013-3121-4","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1126_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.breast.2014.06.016","volume":"23","author":"CKE Parkin","year":"2014","unstructured":"Parkin CKE, Garewal S, Waugh P, Maxwell AJ (2014) Outcomes of patients with lobular in situ neoplasia of the breast: the role of vacuum-assisted biopsy. Breast 23(5):651\u2013655. \n                    https:\/\/doi.org\/10.1016\/j.breast.2014.06.016\n                    \n                  . Epub 2014 Jul 22","journal-title":"Breast"},{"issue":"4","key":"1126_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","volume":"15","author":"WJ Gradishar","year":"2017","unstructured":"Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ et al (2017) NCCN guidelines insights: breast cancer, version 1.2017. J Natl Compr Cancer Netw 15(4):433\u2013451","journal-title":"J Natl Compr Cancer Netw"},{"issue":"8","key":"1126_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1308\/rcsann.2015.0037","volume":"97","author":"R Chester","year":"2015","unstructured":"Chester R, Bokinni O, Ahmed I, Kasem A (2015) UK national survey of management of breast lobular carcinoma in situ. Ann R Coll Surg 97(8):574\u2013577. \n                    https:\/\/doi.org\/10.1308\/rcsann.2015.0037","journal-title":"Ann R Coll Surg"},{"key":"1126_CR6","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","volume":"23","author":"PJ Chuba","year":"2005","unstructured":"Chuba PJ, Hamre MR, Yap J et al (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23:5534\u20135541","journal-title":"J Clin Oncol"},{"issue":"6","key":"1126_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3322\/caac.21321","volume":"65","author":"EM Ward","year":"2015","unstructured":"Ward EM, DeSantis CE, Lin CC, Kramer JL, Jemal A et al (2015) Cancer statistics: breast cancer in situ. CA: Cancer J Clin 65(6):481\u2013495. \n                    https:\/\/doi.org\/10.3322\/caac.21321","journal-title":"CA: Cancer J Clin"},{"issue":"18","key":"1126_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. JNCI 90(18):1371\u20131388","journal-title":"JNCI"},{"issue":"7","key":"1126_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.6004\/jnccn.2015.0107","volume":"13","author":"A Bambhroliya","year":"2015","unstructured":"Bambhroliya A, Chavez-MacGregor M, Brewster AM (2015) Barriers to the use of breast cancer risk reduction therapies. J Natl Compr Cancer Netw 13(7):927\u2013935","journal-title":"J Natl Compr Cancer Netw"},{"key":"1126_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41523-017-0021-y","volume":"3","author":"KD Crew","year":"2017","unstructured":"Crew KD, Albain KS, Hershman DL, Unger JM, Lo SS (2017) How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? NPJ Breast CA 3:20. \n                    https:\/\/doi.org\/10.1038\/s41523-017-0021-y","journal-title":"NPJ Breast CA"},{"key":"1126_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/BCTT.S43763","volume":"6","author":"SA Nazarali","year":"2014","unstructured":"Nazarali SA, Narod SA (2014) Tamoxifen for women at high risk of breast cancer. Breast Cancer 6:29\u201336. \n                    https:\/\/doi.org\/10.2147\/BCTT.S43763","journal-title":"Breast Cancer"},{"issue":"3","key":"1126_CR12","doi-asserted-by":"publisher","first-page":"E279","DOI":"10.1188\/15.ONF.E279-E286","volume":"42","author":"B Jerome-D\u2019Emilia","year":"2015","unstructured":"Jerome-D\u2019Emilia B, Suplee PD, Akincigil A (2015) Validation of the Spanish version of the mammography specific self-efficacy scale. Oncol Nurs Forum 42(3):E279\u2013E286","journal-title":"Oncol Nurs Forum"},{"issue":"3 Suppl","key":"1126_CR13","doi-asserted-by":"publisher","first-page":"16s","DOI":"10.1200\/JOP.2012.000542","volume":"8","author":"DT Farkas","year":"2012","unstructured":"Farkas DT, Greenbaum A, Singhal V, Cosgrove JM (2012) Effect of insurance status on the stage of breast and colorectal cancers in a safety-net hospital. J Oncol Pract 8(3 Suppl):16s\u201321s. \n                    https:\/\/doi.org\/10.1200\/JOP.2012.000542","journal-title":"J Oncol Pract"},{"issue":"1","key":"1126_CR14","doi-asserted-by":"publisher","first-page":"19Y28","DOI":"10.1016\/j.jamcollsurg.2014.03.043","volume":"219","author":"CE Pesce","year":"2014","unstructured":"Pesce CE, Liederbach E, Czechura T, Winchester DJ, Yao K (2014) Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Database. J Am Coll Surg 219(1):19Y28","journal-title":"J Am Coll Surg"},{"issue":"1","key":"1126_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12885-015-1228-7","volume":"15","author":"R Shi","year":"2015","unstructured":"Shi R, Taylor H, McLarty J, Liu L, Mills G, Burton G (2015) Effects of payer status on breast cancer survival: a retrospective study. BMC Cancer 15(1):211. \n                    https:\/\/doi.org\/10.1186\/s12885-015-1228-7","journal-title":"BMC Cancer"},{"issue":"4","key":"1126_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/annonc\/mdv590","volume":"27","author":"SG Smith","year":"2015","unstructured":"Smith SG, Sestak I, Forster A, Partridge A, Side L et al (2015) Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol 27(4):575\u2013590","journal-title":"Ann Oncol"},{"issue":"5","key":"1126_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1006\/pmed.1998.0349","volume":"27","author":"AY Kinney","year":"1998","unstructured":"Kinney AY, Richards C, Vernon SW, Vogel VG (1998) The effect of physician recommendation on enrollment in the breast cancer chemoprevention trial. Prev Med 27(5):713\u2013719","journal-title":"Prev Med"},{"issue":"1","key":"1126_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/1097-0142(19950701)76:1<46::AID-CNCR2820760107>3.0.CO;2-B","volume":"76","author":"A Yeomans-Kinney","year":"1995","unstructured":"Yeomans-Kinney A, Vernon SW, Frankowski RF Weber DM, Bitsura JM, Vogel VG (1995) Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment. Cancer 76(1): 46\u201356. \n                    https:\/\/doi.org\/10.1002\/1097-0142(19950701)76:1%3C46::AID-CNCR2820760107%3E3.0.CO;2-B\n                    \n                  .","journal-title":"Cancer"},{"issue":"2","key":"1126_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40271-015-0134-z","volume":"9","author":"KA Martinez","year":"2016","unstructured":"Martinez KA, Fagerlin A, Witteman HO, Holmberg C, Hawley ST (2016) What matters to women when making decisions about chemoprevention? The Patient 9(2):149\u2013159. \n                    https:\/\/doi.org\/10.1007\/s40271-015-0134-z","journal-title":"The Patient"},{"issue":"3","key":"1126_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12609-016-0216-5","volume":"8","author":"S Hum","year":"2016","unstructured":"Hum S, Wu M, Pruthi S, Heisey R (2016) Physician and patient barriers to breast cancer preventive therapy. Curr Breast CA Rep 8(3):158\u2013164","journal-title":"Curr Breast CA Rep"},{"issue":"1","key":"1126_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13058-017-0826-5","volume":"19","author":"TJ Padamsee","year":"2017","unstructured":"Padamsee TJ, Wills CE, Yee LD, Paskett ED (2017) Decision making for breast cancer prevention among women at elevated risk. Breast Cancer Res 19(1):34. \n                    https:\/\/doi.org\/10.1186\/s13058-017-0826-5","journal-title":"Breast Cancer Res"},{"issue":"4","key":"1126_CR22","first-page":"27","volume":"22","author":"RA Almeida","year":"2001","unstructured":"Almeida RA, Dubay LC, Ko G (2001) Access to care and use of health services by low-income women. Health Care Financ Rev 22(4):27\u201347","journal-title":"Health Care Financ Rev"},{"key":"1126_CR23","unstructured":"Kaiser Family Foundation (2017) Data note: three findings about access to care and health outcomes in medicaid. \n                    https:\/\/www.kff.org\/medicaid\/issue-brief\/data-note-three-findings-about-access-to-care-and-health-outcomes-in-medicaid\/\n                    \n                  . Accessed 20 Jan 2018"},{"issue":"22","key":"1126_CR24","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM et al (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. JNCI 97(22):1652\u20131662","journal-title":"JNCI"},{"key":"1126_CR25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/cncr.20882","volume":"15","author":"AM Brewster","year":"2005","unstructured":"Brewster AM, Christo DK, Lai H, Helzlsouer K (2005) Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits. Cancer 15:1147\u20131153","journal-title":"Cancer"},{"issue":"10","key":"1126_CR26","first-page":"663","volume":"13","author":"KC Kadakia","year":"2015","unstructured":"Kadakia KC, Henry NL (2015) Adjuvant endocrine therapy in premenopausal women with breast cancer. Clin Adv Hematol Oncol 13(10):663","journal-title":"Clin Adv Hematol Oncol"},{"key":"1126_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/IJWH.S3894","volume":"1","author":"EM Messalli","year":"2009","unstructured":"Messalli EM, Scaffa C (2009) Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update. Int J Women\u2019s Health 1:11","journal-title":"Int J Women\u2019s Health"},{"issue":"10","key":"1126_CR28","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1097\/GME.0000000000000441","volume":"22","author":"Y Takeuchi","year":"2015","unstructured":"Takeuchi Y, Hamaya E, Taketsuna M, Sowa H (2015) Safety of 3-year raloxifene treatment in Japanese postmenopausal women aged 75 years or older with osteoporosis: a postmarketing surveillance study. Menopause 22(10):1134\u20131137","journal-title":"Menopause"},{"issue":"2","key":"1126_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10549-012-2089-2","volume":"134","author":"EA Waters","year":"2012","unstructured":"Waters EA, McNeel TS, Stevens WM, Freedman AN (2012) Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat 134(2):875\u2013880. \n                    https:\/\/doi.org\/10.1007\/s10549-012-2089-2","journal-title":"Breast Cancer Res Treat"},{"issue":"27","key":"1126_CR30","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1200\/JCO.2009.25.9655","volume":"28","author":"DL Hershman","year":"2010","unstructured":"Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, Fehrenbacher L, Lin Gomez S, Miles S, Neugut AI (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28(27):4120\u20134128","journal-title":"J Clin Oncol"},{"issue":"24","key":"1126_CR31","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1200\/JCO.2004.05.192","volume":"22","author":"SL Bober","year":"2004","unstructured":"Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM (2004) Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors. J Clin Oncol 22(24):4951\u20134957","journal-title":"J Clin Oncol"},{"issue":"1","key":"1126_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.socscimed.2004.04.022","volume":"60","author":"B Jerome-D\u2019Emilia","year":"2005","unstructured":"Jerome-D\u2019Emilia B, Begun JW (2005) Diffusion of breast conserving surgery in medical communities. Soc Sci Med 60(1):143\u2013151","journal-title":"Soc Sci Med"},{"issue":"4","key":"1126_CR33","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjsurg.2015.10.021","volume":"211","author":"S Shahbazi","year":"2016","unstructured":"Shahbazi S, Woods SJ (2016) Influence of physician, patient, and health care system characteristics on the use of outpatient mastectomy. Am J Surg 211(4):802\u2013809","journal-title":"Am J Surg"},{"issue":"24","key":"1126_CR34","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1200\/JCO.2007.10.9272","volume":"25","author":"JF Waljee","year":"2007","unstructured":"Waljee JF, Hawley S, Alderman AK, Morrow M, Katz SJ (2007) Patient satisfaction with treatment of breast cancer: does surgeon specialization matter? J Clin Oncol 25(24):3694\u20133698","journal-title":"J Clin Oncol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-019-1126-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-019-1126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-019-1126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T20:28:19Z","timestamp":1589660899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-019-1126-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1007\/s10552-019-1126-4","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"14 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}